We are live on !
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$8.83M
(-3.5%)
Cap. Flow
-$21M
Cap. Flow % of AUM
Cap. Flow %
-8.67%
Top 10 Holdings %
Top 10 Hldgs %
68.56%
Holding
127
New
18
Increased
18
Reduced
12
Closed
20
Avg Time Held
2
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calumet Specialty Products
CLMT
|
+$6.99M |
| 2 |
FTAI Aviation
FTAI
|
+$4.2M |
| 3 |
Upland Software
UPLD
|
+$4.19M |
| 4 |
Smith & Wesson
SWBI
|
+$3.62M |
| 5 |
Meta Platforms (Facebook)
META
|
+$3.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$33.3M |
| 2 |
Pfizer
PFE
|
+$12.4M |
| 3 |
Microsoft
MSFT
|
+$6.16M |
| 4 |
RXDX
Ignyta, Inc.
RXDX
|
+$1.81M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.49% |
| 2 | Technology | 8.14% |
| 3 | Industrials | 7.13% |
| 4 | Financials | 7.01% |
| 5 | Energy | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Bristol-Myers Squibb
BMY
$122B
| $141K | 0.06% |
2,225
| – | – |
2017 Q1
4 quarters
|
|
|
77
Microsoft
MSFT
$3.93T
| $128K | 0.05% |
1,400
-67,350
| -98% | -$6.16M |
2013 Q2
19 quarters
|
|
78
FNB Corp
FNB
$6.13B
| $120K | 0.05% |
8,905
| – | – |
2014 Q3
14 quarters
|
|
|
ORIT
79
DELISTED
Oritani Financial Corp. New
ORIT
| $120K | 0.05% |
7,800
| – | – |
2013 Q2
19 quarters
|
|
80
Cousins Properties
CUZ
$4.55B
| $117K | 0.05% |
3,357
| – | – |
2015 Q1
12 quarters
|
|
81
Abeona Therapeutics
ABEO
$253M
| $101K | 0.04% |
+281
| New | +$104K |
2018 Q1
0 quarters
|
|
82
Tempest Therapeutics
TPST
$10.5M
| $91K | 0.04% |
38
| – | – |
2017 Q2
3 quarters
|
|
83
MBody AI Ltd. Ordinary Share
MBAI
$42.1M
| $84K | 0.03% |
97
| – | – |
2017 Q3
2 quarters
|
|
84
Medtronic
MDT
$121B
| $84K | 0.03% |
1,050
| – | – |
2014 Q3
14 quarters
|
|
85
Chemours
CC
$1.92B
| $66K | 0.03% |
1,360
| – | – |
2015 Q3
10 quarters
|
|
86
Ford
F
$49.6B
| $55K | 0.02% |
5,000
| – | – |
2017 Q3
2 quarters
|
|
87
DELISTED
Affimed
AFMD
| $44K | 0.02% |
+2,400
| New | +$45.3K |
2018 Q1
0 quarters
|
|
88
Antelope Enterprise Holdings
AEHL
$183M
| – | – |
0
| – | – |
2013 Q2
19 quarters
|
|
89
Editas Medicine
EDIT
$361M
| $33K | 0.01% |
+1,000
| New | +$35.6K |
2018 Q1
0 quarters
|
|
90
Alnylam Pharmaceuticals
ALNY
$31B
| $30K | 0.01% |
249
| – | – |
2017 Q3
2 quarters
|
|
91
Lite Strategy Inc
LITS
$35M
| $29K | 0.01% |
700
| – | – |
2017 Q3
2 quarters
|
|
|
PBCT
92
DELISTED
People's United Financial Inc
PBCT
| $28K | 0.01% |
1,500
| – | – |
2015 Q1
12 quarters
|
|
93
Scotiabank
BNS
$111B
| $25K | 0.01% |
400
| – | – |
2015 Q1
12 quarters
|
|
94
Eagle Materials
EXP
$5.22B
| $23K | 0.01% |
228
| – | – |
2013 Q2
19 quarters
|
|
95
Eli Lilly
LLY
$1.12T
| $23K | 0.01% |
300
| – | – |
2013 Q3
18 quarters
|
|
|
ABLX
96
DELISTED
Ablynx NV
ABLX
| $11K | ﹤0.01% |
+200
| New | +$9.9K |
2018 Q1
0 quarters
|
|
97
DELISTED
DigitalBridge
DBRG
| $8K | ﹤0.01% |
367
| – | – |
2017 Q1
4 quarters
|
|
98
Starwood Property Trust
STWD
$4.61B
| $8K | ﹤0.01% |
400
| – | – |
2013 Q2
19 quarters
|
|
99
Alerian MLP ETF
AMLP
$12.7B
| $6K | ﹤0.01% |
120
| – | – |
2015 Q1
12 quarters
|
|
|
SCU
100
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $5K | ﹤0.01% |
200
| – | – |
2014 Q2
15 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q1 2018 Portfolio in Review
As of Q1 2018, David M. Knott held 127 positions worth $243M, down 3.5% from $251M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
David M. Knott withdrew a net $21M in Q1 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Ignyta, Inc., an estimated $1.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.
Against the trend, David M. Knott opened a new position in Calumet Specialty Products worth $6.67M.
- David M. Knott's largest Q1 2018 buy was Calumet Specialty Products: 945,558 shares worth $6.67M.
- David M. Knott added most to FTAI Aviation in Q1 2018, an estimated $4.2M increase.
- David M. Knott's biggest Q1 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $33.3M.
- David M. Knott fully exited Ignyta, Inc. in Q1 2018, selling an estimated $1.81M.
- David M. Knott's ten largest holdings make up 69% of its $243M portfolio in Q1 2018.
- David M. Knott opened 18 new positions and closed 20 in Q1 2018.
- David M. Knott's portfolio value fell 3.5% quarter-over-quarter to $243M.
Based on David M. Knott's 13F filing for Q1 2018, filed 11 May 2018.